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Greek schoolgirl of the Attica region
Chariclia V Loupa1*, Konstantina Tzanetou2, Ioannis Kotsantis1, Stylianos Panopoulos1 and Moyssis Lelekis1
Abstract
In August 2009, one case of autochthonous malaria due to Plasmodium vivax was diagnosed in Greece in a young
woman residing in the Eastern Attica region. The source of infection could not be identified. No other
autochthonous malaria cases have been described in the Attica region since 1974. This was a sporadic case with
no evidence of further local transmission, and no more cases have been reported in Attica up to now, two years
later.
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Background
In non-endemic countries, malaria cases are mostly
imported (from travelers or immigrants), but blood
transfusion malaria, or malaria in transplant recipients,
or even cases of “airport malaria” can occasionally be
seen [1]. Greece has been malaria free since 1974. How-
ever, rare cases of autochthonous malaria are occasion-
ally reported. Recently, in August 2011, an
announcement was posted by European Centres for Dis-
ease Prevention and Control (ECDC) and American
Centers for Disease Control and Prevention (CDC) that
six autochthonous malaria cases were reported in south-
ern Greece [2,3]. An autochthonous case in a schoolgirl
in the Attica region in 2009 is hereby described.
Case presentation
A 17-year-old young woman of Greek origin, living in the
Eastern Attica region, was admitted to hospital (mid-
August, 2009), because of high fever (up to 40.3°C) of
abrupt onset with chills for eight days. She also reported
sore throat, headache, remarkable weakness and sweating
with unpleasant smell. Fever was almost periodic, being
higher every second day. Anti-pyretic drugs were causing
lysis with excess sweating. Her past medical history was
unremarkable. She denied travelling abroad and had no
history of blood transfusion. Upon admission, patient was
in good condition, and physical examination revealed mild
hepatosplenomegaly. There were multiple skin lesions sug-
gesting insect bites, especially on lower limbs. During the
first 48 hours of hospitalization, she had fever up to 40°C,
symptomatically treated with paracetamol. Initial blood
evaluation showed normocytic, normochromous anaemia
(haematocrit 31.3%, MCV = 89.6 fL, MCHC = 32.3),
thrombocytopaenia (platelets 48,000/μL), with a normal
leukocyte count. Liver function tests yielded slightly
abnormal results: AST 28 u/L, ALT 71 u/L (reference
range < 40), LDH 943 u/L (reference range 230-450), and
total bilirubin 1.2 mg/dL (reference range < 1,0). Kidney
function tests and coagulation study were normal. ESR
was 58 mm, and CRP 139 mg/L (reference range < 5).
Chest x-ray and urinalysis were normal. Two sets of blood
cultures and urine culture were negative. Viral (cytomega-
lovirus, Epstein-Barr virus), bacterial (brucella) and parasi-
tic (Toxoplasma, Leishmania) serology was negative, and
throat swab PCR for H1N1 antigens was also negative.
Based on serology (Ra-test, ANA, anti-DNA), there was
no evidence of systemic disease. Ultrasonography of the
upper abdomen showed enlarged liver and spleen (17.2
and 14.1 cm, respectively). The initial Giemsa-stained per-
ipheral blood smear was negative for Plasmodium. In a
second peripheral blood smear, obtained on the third hos-
pital day, Plasmodium parasites were identified. The
patient was started on mefloquine. When the smear was
re-examined by an experienced microbiologist, the para-
site was identified as Plasmodium vivax according to mor-
phological characteristics of trophozoites, immature/
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mature schizonts, and gametocytes (Figure 1A-D). Parasi-
taemia was approximately 3%. After completing meflo-
quine therapy (750 mg po ×1, then 500 mg po × 1 12 h
later), the patient’s condition improved and after assess-
ment of G-6-PD levels, she was discharged on primaquine
(30 mg base po ×1) for 14 days. Seen as an outpatient, she
remains in good health and relapse-free to September
2011 (two years after discharge).
The young woman is of Greek origin and living in
Nea Makri. This small summer holiday town of 14,809
permanent residents is located in Eastern Attica region,
32 km from the city of Athens and 12 km from “El.
Venizelos” International Airport [4]. Many immigrants
from endemic countries live in this area, and they work
at plant nurseries located approximately 10 km from the
small town. There are also still water pools and even
swamps at a 10 km distance. The patient had no travel
history in malaria endemic countries. She did not men-
tion any visits to the airport, and she had no history of
blood transfusion. She had a schoolmate from Africa,
who was apparently healthy. A limited enquiry that was
conducted did not reveal other people with malaria-like
symproms in the patient’s family or school.
Discussion and conclusion
In Greece, malaria is among the mandatory reported
diseases. According to official data, 20-30 new cases of
malaria are reported every year [5]. Like all non-
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Figure 1 Plasmodium vivax in Giemsa-stained thin blood smear with all developmental stages present in peripheral blood. (A) Growing
amoeboid trophozoite in enlarged red blood cell (RBC) with eosinophilic stippling (schuffner’s dots). (B) Immature schizonts with clumps of
brown pigment almost fill the enlarged RBCs. (C) Mature schizont with merozoites (about 14) and clumped pigment. (D) Macrogametocyte with
diffuse brown pigment and eccentric compact chromatin.
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endemic countries, cases are mostly imported (from tra-
velers or immigrants), but there are also few reports of
blood transfusion malaria [1]. However, a few auto-
chthonous cases of malaria were reported in Thrace
(Northern Greek region) [6-8], in the mid- and late
Nineties. Since then, there were no more autochthonous
cases until 2009, when six cases of autochthonous
malaria were reported (through the European Surveil-
lance System - TESSy) and one again in 2010, all resid-
ing in the same area of Evrotas, a small agricultural and
wetland area (Lakonia, Peloponnese, southern Greece)
[9,10]. These cases were all caused by P. vivax [2]. Since
June 2011, another six cases of autochthonous malaria
were reported [2,3]. All six cases were diagnosed with P.
vivax malaria. Four of these were again from Evrotas
region. One case is a young Roma child, and three cases
are adult Greek citizens not belonging to a minority
group. The two remaining cases are in adult Greek citi-
zens that reside close to the town of Chalkida, in the
district of Evoia, where no previous autochthonous
malaria cases had been reported. Both the Lakonia and
Evoia districts have a large population of non-documen-
ted illegal migrant farm workers from malaria-endemic
countries. In August 2011, a P. vivax malaria infection
was diagnosed in a Romanian citizen who had been
working in agriculture in Evrotas region [11].
The described autochthonous malaria case was diag-
nosed in August 2009. It was reported to KEELPNO
(the Greek Centers for Disease Control and Prevention)
through the mandatory notification system. This is the
only case of autochthonous malaria in Attica (Athens
city and suburbs region) before 2011. It was caused by
P.vivax, as all the Laconia and Evoia cases, and, as pre-
viously noted, in this particular Attica area a lot of
immigrants reside and work. This was a sporadic case
with no evidence of further local transmission.
The most likely explanation of the few reported auto-
chthonous cases is limited transmission of the disease to
nearby residents or workers by local mosquitoes (vec-
tors), infected from undiagnosed imported malaria cases
or asymptomatic gametocyte carriers infected outside
Greece. This is attributed to the large number of docu-
mented and non-documented (illegal) immigrants from
endemic countries of Asia and Africa. Also, climate
change, causing high temperatures during summer time,
is favourable for mosquito growth [10].
Isolated autochthonous cases caused by P. vivax, Plas-
modium falciparum and Plasmodium ovale have been
reported in other European countries, such as in Spain,
France, Italy and Germany. In Spain, a case of malaria
was reported from the Aragon region in 2010 [12], and
there was also one in 2001 that may have been airport
malaria [13]. One case was diagnosed in Corsica, France,
and two in Marseille, in spring and summer 2006
[14,15]. In Italy, there were two cases in 1997-1998,
with one of them linked to an imported case from India
[5,16] and one in late Eighties [17]. In Germany, there
were two cases in a paediatric ward in 1997 [18]. Such
cases never resulted in established local transmission
involving more than a few cases.
During 2010 and 2011, attention was paid to mos-
quito-borne infections in Greece because of West Nile
virus outbreaks and KEELPNO has responded by enhan-
cing its surveillance system and intensifying mosquito
control. Efforts to destroy mosquitoes using insecticides
are currently undertaken by the Greek government [19].
Although malaria risk in Greece remains extremely
low, and the country has implemented control measures,
individual measures to prevent mosquito bites, such as
using insect repellent when outdoors during the peak-
biting period for mosquitoes (dusk and dawn), seem rea-
sonable. Also, health practitioners must include malaria
in the differential diagnosis, and try to rapidly identify
and report suspected malaria cases to respective authori-
ties. Diagnosis is based on microscopy (blood smears)
and/or serology. When there is a high suspicion index
for malaria, repeated peripheral blood smears should be
examined, drawn every six to 12 hours for a minimum
of three days, preferably upon fever or chills [20].
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